RVA.AX - REVA Medical, Inc.

ASX - ASX Delayed Price. Currency in AUD

REVA Medical, Inc.

5751 Copley Drive
San Diego, CA 92111
United States

IndustryMedical Appliances & Equipment
Full Time Employees49

Key Executives

Ms. Regina E. GrovesChief Exec. Officer & DirectorN/AN/A60
Mr. Robert B. StockmanCo-Founder and DirectorN/AN/A64
Mr. Richard M. KimesSr. VP of Operations319.02kN/A56
Mr. Jeffrey A. AndersonSr. VP of Clinical and Regulatory AffairsN/AN/A51
Ms. Brandi L. Roberts CPA, M.B.A.CFO, Company Sec. & Sr. VPN/AN/A44
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


REVA Medical, Inc., a medical device company, focuses on the commercialization of minimally invasive medical devices for the treatment of conditions in the human body. It is developing Fantom, a drug-eluting bioresorbable stent to treat vascular disease in humans. The company was formerly known as MD3, Inc. and changed its name to REVA Medical, Inc. in March 2002. REVA Medical, Inc. was founded in 1998 and is headquartered in San Diego, California.

Corporate Governance

REVA Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.